VolitionRx Limited (VNRX)
AMEX·Healthcare·Medical - Diagnostics & Research
$2.72
-0.33%
Mkt Cap $14.70M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 31, 2026 | $753.58K | $420.00K | -44.27% | -$0.04 | -$0.05 | -25.00% | — | — |
| Q4 2025 Nov 13, 2025 | $714.08K | $627.28K | -12.16% | -$0.04 | -$0.04 | +0.00% | — | — |
| Q3 2025 Aug 14, 2025 | $881.03K | $406.69K | -53.84% | -$0.05 | -$0.06 | -20.00% | — | — |
| Q2 2025 May 15, 2025 | $1.08M | $246.38K | -77.27% | -$0.06 | -$0.06 | +0.00% | — | — |
| Q1 2025 Mar 31, 2025 | $545.34K | $191.66K | -64.86% | -$0.06 | -$0.06 | +0.00% | — | — |
| Q4 2024 Nov 14, 2024 | $545.34K | $474.52K | -12.99% | -$0.07 | -$0.07 | +0.00% | — | — |
| Q3 2024 Aug 14, 2024 | $480.00K | $395.80K | -17.54% | -$0.09 | -$0.08 | +11.11% | — | — |
| Q2 2024 May 13, 2024 | $390.00K | $171.53K | -56.02% | -$0.11 | -$0.10 | +9.09% | — | — |
| Q1 2024 Mar 25, 2024 | $450.00K | $243.97K | -45.78% | -$0.11 | -$0.11 | +0.00% | — | — |
| Q4 2023 Nov 14, 2023 | $450.00K | $165.21K | -63.29% | -$0.12 | -$0.11 | +8.33% | — | — |
| Q3 2023 Aug 14, 2023 | $270.00K | $216.31K | -19.89% | -$0.13 | -$0.14 | -7.69% | — | — |
| Q2 2023 May 10, 2023 | $420.00K | $149.81K | -64.33% | -$0.14 | -$0.15 | -7.14% | — | — |
| Q1 2023 Mar 15, 2023 | $220.00K | $119.72K | -45.58% | -$0.15 | -$0.13 | +13.33% | — | — |
| Q4 2022 Nov 14, 2022 | $94.33K | $32.71K | -65.32% | -$0.15 | -$0.14 | +6.67% | — | — |
| Q3 2022 Aug 10, 2022 | $110.75K | $39.75K | -64.11% | -$0.15 | -$0.14 | +6.67% | — | — |
| Q2 2022 May 11, 2022 | $10.02M | $114.21K | -98.86% | -$0.01 | -$0.14 | -900.00% | — | — |
| Q1 2022 Mar 30, 2022 | $16.22K | $14.24K | -12.21% | -$0.14 | -$0.15 | -7.14% | — | — |
| Q4 2021 Nov 10, 2021 | $17.84K | $25.48K | +42.86% | -$0.10 | -$0.13 | -30.00% | — | — |
| Q3 2021 Aug 11, 2021 | $25.00K | $24.78K | -0.87% | -$0.12 | -$0.10 | +16.67% | — | — |
| Q2 2021 May 11, 2021 | $25.53K | $25.53K | +0.00% | -$0.12 | -$0.12 | +0.00% | — | — |